APOSIA: Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis

Sponsor
Elsan (Other)
Overall Status
Recruiting
CT.gov ID
NCT05145725
Collaborator
European Clinical Trial Experts Network (Other), Asociación European Spine Study Group (Other)
866
1
180
4.8

Study Details

Study Description

Brief Summary

The study population concerns adolescent patients with idiopathic scoliosis which requires surgical management and who have a longer waiting period of 6 months.

The aim of this study is to research the predictive factors of an improvement in the quality of life of adolescents who have had surgery.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Quality of life questionnaires

Study Design

Study Type:
Observational
Anticipated Enrollment :
866 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Instrumented POsterolateral Arthrodesis for Adolescent Idiopathic Scoliosis: Observational Study
Actual Study Start Date :
Mar 18, 2021
Anticipated Primary Completion Date :
Mar 18, 2028
Anticipated Study Completion Date :
Mar 18, 2036

Arms and Interventions

Arm Intervention/Treatment
Idiopathic scoliosis in adolescents requiring surgery

Behavioral: Quality of life questionnaires
Different questionnaires to fill : SRS-22r, SF-36 score, TAPS, KIDSCREEN10

Outcome Measures

Primary Outcome Measures

  1. Factors associated with an improvement in the SRS-22r score [1 year]

    Factors associated with an improvement in the SRS-22r score, 1 year after surgery, will be sought among the initial characteristics (before surgery) and within 3 months after surgery. An improvement in SRS-22r score is defined as an increase in the total score at 1 year of at least 10% from value.

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 20 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient between 12 and 20 years old

  • Scoliosis in adolescents for whom surgery has been proposed based on radiological criteria (Cobb angle> 25 ° for thoracolumbar and lumbar scoliosis,> 35 ° for thoracic scoliosis and> 40 ° for double major scoliosis)

  • Patient affiliated or beneficiary of a social security scheme or attached to a beneficiary of a social security scheme

  • Patient and legal representative having been informed and not opposing this research

Exclusion Criteria:
  • Patient over 20 years old

  • Non-surgical scoliosis

  • Refusal to participate in the study by the child or parents

Contacts and Locations

Locations

Site City State Country Postal Code
1 Clinique du dos Bruges France 33520

Sponsors and Collaborators

  • Elsan
  • European Clinical Trial Experts Network
  • Asociación European Spine Study Group

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elsan
ClinicalTrials.gov Identifier:
NCT05145725
Other Study ID Numbers:
  • 2020-A03069-30
First Posted:
Dec 6, 2021
Last Update Posted:
Dec 6, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2021